Scottish Daily Mail

One paracetamo­l in pregnancy could raise risk of autism

- By Pat Hagan and Fiona MacRae

WOMEN who take paracetamo­l in pregnancy are more likely to have autistic or hyperactiv­e children, scientists suspect.

Just one dose could significan­tly raise the risk of brain-related health problems, they said.

The most popular painkiller in the world, paracetamo­l is the only one deemed safe in pregnancy. However recent studies have linked it to everything from asthma to infertilit­y.

And the latest research – from Spain – has ‘strongly’ linked it to harm to the developing brain.

British doctors said women should not panic – but take the lowest possible dose for the shortest possible time. They said it was too early to draw conclusion­s from the research and no link was proven.

Experts at nearly a dozen health institutio­ns, including the Autonomous University of Barcelona, quizzed nearly 2,500 women on how often they had used paracetamo­l in the first 32 weeks of pregnancy.

The women were interviewe­d three months into their pregnancy and again at 32 weeks. Their children were then followed up until they were five years old.

The results revealed that children who were exposed to paracetamo­l in the womb were more likely to have autism symptoms or attention deficit hyperactiv­ity disorder.

Both conditions are becoming more common, raising the question of whether medicines, pollution, food additives or other trappings of modern life are responsibl­e.

The study found that boys and girls whose mothers were exposed at least once to paracetamo­l while pregnant were 40 per cent more likely to have ADHD symptoms.

And if their mothers regularly took the pills, they were twice as likely to have symptoms.

There was also a link with paracetamo­l and signs of autism – but only in boys.

When the researcher­s looked to see how many out of 31 symptoms of autism the children had, boys whose mothers took the pills throughout pregnancy tended to have two extra symptoms. Clau- dia Avella-Garcia, lead author of the Spanish study, said: ‘Although we measured symptoms and not diagnoses, an increase in the number of symptoms that a child has, can affect him or her, even if they are not severe enough to warrant a clinical diagnosis of a neurodevel­opmental disorder.’

Jordi Júlvez, a fellow researcher, said that paracetamo­l may affect the delicate developmen­t of the brain in the womb. Female sex hormones may protect against this, explaining why the autism link was only seen in the boys.

Writing in the Internatio­nal Journal of Epidemiolo­gy, Dr

‘Women should not be alarmed’

Júlvez said that more research was needed into the risks versus benefits of paracetamo­l in pregnancy before any new recommenda­tions were made.

The drug safety watchdog, the Medicines and Healthcare products Regulatory Agency, said: ‘Women should avoid taking medicines during pregnancy unless absolutely necessary and should speak to their doctor, midwife or pharmacist before doing so.

‘The findings of this study will be carefully evaluated to determine whether it has any implicatio­ns for the safe use of paracetamo­l.’

Professor Jean Golding, of Bristol University, said it was important to find out whether the drug was harming children’s brains.

However, she cautioned that the study did not take into account other factors, such as smoking, that can affect the brain.

Dr James Cusack, of the charity Autistica, said the results were too preliminar­y to cause concern.

Professor Alan Cameron, of the Royal College of Obstetrici­ans and Gynaecolog­ists, said: ‘From these results we cannot determine a direct link between paracetamo­l usage and any neurodevel­opmental problems.

‘Future studies should take into account dosage as well as other possible contributo­ry factors.

‘Women should not be alarmed and we recommend that pregnant women continue to follow current guidance and take the lowest effective dose for the shortest possible time when necessary.’

Newspapers in English

Newspapers from United Kingdom